Education
About Us
Working with TipRanks
Follow Us
Sight Sciences (SGHT)
NASDAQ:SGHT
Earnings Data
Report Date
Aug 07, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.27Last Year’s EPS
-0.25Same Quarter Last Year
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: 12.87%
|Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with solid performance in the surgical glaucoma segment and positive reception of new product launches, but faced challenges with revenue declines, tariff costs, and the lack of reimbursement for TearCare. The company's strategic initiatives and cost management are showing progress, yet external market conditions and reimbursement hurdles remain significant concerns.Company Guidance
In the first quarter of 2025 earnings call, Sight Sciences provided guidance for the full year, reaffirming its revenue expectations of approximately $70 million to $75 million and adjusting its operating expense guidance to a range of $101 million to $105 million, reflecting a focus on cost controls to offset tariff impacts on goods imported from China. The company reported total revenue of $17.5 million for the first quarter, with surgical glaucoma revenue accounting for $17.1 million and dry eye revenue at $400,000. Despite a 9% year-over-year decrease in total revenue attributed to new Medicare coverage restrictions on multiple MIGS procedures, Sight Sciences emphasized its long-term strategic initiatives, including advancing its product pipeline, expanding manufacturing outside China, and pursuing reimbursement decisions for its TearCare technology. The company's gross margin remained stable at 86%, while operating expenses decreased by 7%, contributing to a net loss of $14.2 million for the quarter.Solid First Quarter Revenue
Sight Sciences reported a total revenue of $17.5 million for the first quarter of 2025, reflecting the significance of their interventional technologies despite a dynamic MIGS market.
Stable Surgical Glaucoma Revenue
Surgical glaucoma revenue for Q1 2025 was $17.1 million, with only a slight decline in sequential ordering accounts despite Medicare coverage restrictions, indicating resilience in the market.
Next-Generation OmniEdge Launch
The company launched OmniEdge, a new addition to their MIGS platform, receiving positive early reception from surgeons for its advanced technology.
Strong Gross Margins
Gross margin for the first quarter was 86%, remaining flat compared to the same period in the prior year, indicating stable cost management.
Reduced Net Loss
Net loss for the first quarter was $14.2 million, or $0.28 per share, compared to a net loss of $16.3 million, or $0.33 per share, for the first quarter of 2024, showing improved financial management.
---
SGHT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SGHT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $3.03 | $3.08 | +1.65% |
Mar 05, 2025 | $2.42 | $2.49 | +2.89% |
Nov 07, 2024 | $4.68 | $4.23 | -9.62% |
Aug 01, 2024 | $7.42 | $6.31 | -14.96% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Sight Sciences (SGHT) report earnings?
Sight Sciences (SGHT) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
What is Sight Sciences (SGHT) earnings time?
Sight Sciences (SGHT) earnings time is at Aug 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SGHT EPS forecast?
SGHT EPS forecast for the fiscal quarter 2025 (Q2) is -0.27.
---